Annual report [Section 13 and 15(d), not S-K Item 405]

Statements of Operations and Comprehensive Loss

v3.26.1
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 9,121 $ 20,014
General and administrative 20,396 12,103
Total operating expenses 29,517 32,117
Loss from operations (29,517) (32,117)
Other income (expenses):    
Interest income 1,012 1,261
Interest expense (71) (71)
Change in fair value of warrant liability 2,021 (5,802)
Total other income (expenses) 2,962 (4,612)
Net loss (26,555) (36,729)
Other comprehensive loss:    
Unrealized loss on marketable securities, net (1)
Net comprehensive loss (26,556) (36,729)
Dividend to Series B-1 preferred stockholders (1,095)
Net loss attributable to common stockholders $ (26,555) $ (37,824)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (1.67) $ (5.65)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (1.67) $ (5.65)
Weighted-average shares outstanding used in computing net loss per share, basic (in Shares) 15,886,876 6,698,513
Weighted-average shares outstanding used in computing net loss per share, diluted (in Shares) 15,886,876 6,698,513